China MedTech CEO Roundtable Q3

Q3. Assuming fast expansion of VBP and DRG, how would you see the GTM model will evolve in MedTech in next 3-5 years?
A. Companies will move toward an at-scale direct model across China, and only leverage distributors as logistics providers
B. Companies will move toward direct model in VBP-impacted regions, and only leverage distributors as a logistic provider
C. GTM model will not change significantly in this time frame
D. Others

1题 | 被引用0次

模板修改
使用此模板创建